Top 10 Mid Cap Stocks To Watch Right Now

"And, by the way, the bulk of the billions in Berkshire Hathaway has come from the better businesses. ... And most of the other people who've made a lot of money have done so in high-quality businesses."
-- Charlie Munger�

At Tier 1 Investments, a Motley Fool Real-Money Portfolio, I seek out and invest in elite businesses. These include companies with the most valuable brands, best management, superior products and services, and strongest competitive advantages. This strategy has proved to be very effective, with Tier 1 returning 49% since its inception nearly two ago, which has outperformed the S&P 500 by nearly five percentage points during that time.

But I also appreciate the power of dividend growth when it comes to earning market-beating returns. In fact, a study by C. Thomas Howard published in Advisor Perspectives found that for every percentage point a stock's yield rises, its annual return increases by 0.22 percentage points if it's a large cap, 0.25 if it's a mid cap, and 0.46 if it's a small cap. Even better, Howard found that dividend-growing stocks outperformed dividend cutters by 10 percentage points per year from 1973 to 2010 and beat both flat- and no-dividend stocks. And the icing on the cake is that Howard showed that this outperformance came with a third less volatility. Higher returns, less volatility-induced stress, and a steadily growing income stream -- three powerful aspects of dividend growth investing that can help you grow your wealth.

Top 10 Mid Cap Stocks To Watch Right Now: Rosetta Genomics Ltd (ROSG)

Rosetta Genomics Ltd., incorporated on March 9, 2000, is seeking to develop and commercialize diagnostic tests based on discovered group of genes known as microRNAs. The Company has established a clinical laboratory improvement amendment (CLIA)-certified laboratory in Philadelphia, which enables it to develop, validate and commercialize its own diagnostic tests applying its microRNA technology. In July 2011, the Company launched its fifth product - miRview lung. As of December 31, 2011, the Company launched five tests based on its five microRNA technologies: miRview mets; miRview mets2; miRview squamous; miRview meso, and miRview lung.

Rimonim Consortium

In January 2011, the Company joined the Rimonim Consortium, which is supported by the Office of the Chief Scientist at the Ministry of Industry, Trade and Labor of the State of Israel, or the OCS. The purpose of the consortium is to develop RNA interference, or RNAi, -based therapeutics.

Rosetta Green

Rosetta Green Ltd. is an Israeli subsidiary of the Company, which was established to leverage its capabilities into the areas of cleantech and plant biotech by using its microRNA technologies to develop plants and algae more suitable for various applications, such as feedstocks for biofuels and agriculture. Research at the Rosetta Green project has been shown to develop algal strains with oil content, to discover potential novel microRNAs from commercially-important algae and to identify drought-regulated microRNAs in plants.

The Company competes with Pathwork Diagnostics, Inc., Biotheranostics, Inc., Combimatrix Corporation, Alnylam Pharmaceuticals, Inc., Asuragen Inc., Exiqon A/S, Life Technologies Corporation, Isis Pharmaceuticals, Merck & Co., Inc., Santaris Pharma A/S, and Regulus Therapeutics.

Advisors' Opinion:

• [By Peter Graham]

  The Q3 2014 earnings report for molecular diagnostic company Myriad Genetics, Inc (NASDAQ: MYGN) is due out after the market closes on Tuesday and things could get ugly since unlike potential diagnostic stock peers such as Rosetta Genomics Ltd (NASDAQ: ROSG) and mid cap diagnostic stock Quest Diagnostics Inc (NYSE: DGX), it�� the most shorted stock on the Nasdaq with short interest of 52.07%. Aside from the Myriad Genetics earnings report, it should be said that Rosetta Genomics Ltd last reported earnings on March 31st and those�earnings were for the full year 2013 while�Quest Diagnostics reported Q1 2014 earnings on April 24th that were a disappointment due to restructuring costs and harsh winter weather. However, Myriad Genetics has been the more interesting stock as Medicare reimbursement rate increases and the lost of a court bid to block competition while a patent-infringement case is pending have sent its shares all over the place.

• [By John Udovich]

  On Tuesday, small cap cancer diagnostic stock Myriad Genetics, Inc (NASDAQ: MYGN) jumped 11.42% in one day, meaning its worth taking a closer look at the stock along with the performance of small cap cancer diagnostic stocks like Rosetta Genomics Ltd (NASDAQ: ROSG) and�Genomic Health, Inc (NASDAQ: GHDX) plus mid cap diagnostic stock Quest Diagnostics Inc (NYSE: DGX). I should mention that we have had�Myriad Genetics in our SmallCap Network Elite Opportunity (SCN EO) portfolio since February 5th and we are already up 18.50%���a nice return in just two weeks time.

• [By John Udovich]

  Small cap genomics stocks Rosetta Genomics Ltd (NASDAQ: ROSG), Genomic Health, Inc (NASDAQ: GHDX) and CollabRx Inc (NASDAQ: CLRX) are at the forefront of genomics testing�or research. I should mention that Wikipedia defines genomics�as a�discipline in genetics that applies recombinant DNA, DNA sequencing methods and bioinformatics to sequence, assemble and analyze the function and structure of genomes (the complete set of DNA within a single cell of an organism). A 2013 Booz Allen Hamilton report on the sector noted that in�2011, the US genetic and genomic clinical testing market size was estimated to be $5.9 billion while the�number of available tests has grown substantially from 1,680 just 4 years ago to 2,886 in 2012.

Top 10 Mid Cap Stocks To Watch Right Now: Orbital Sciences Corporation(ORB)

Orbital Sciences Corporation develops and manufactures small and medium-class rockets and space systems for commercial, military, and civil government customers. The company operates in three segments: Launch Vehicles, Satellites and Space Systems, and Advanced Space Programs. The Launch Vehicles segment develops and produces small-class launch vehicles that place satellites into low-Earth orbit; interceptor launch vehicles for missile defense systems, including interceptor boosters; and target launch vehicles, such as suborbital rockets and their principal subsystems, as well as payloads carried by vehicles used in the development and testing of missile defense systems. The Satellites and Space Systems segment develops and produces communications satellites that provide cable and direct-to-home television distribution, business data network connectivity, regional mobile telephony, and other space-based communications services; and science and remote sensing satellites tha t are used to conduct space-related scientific research, collect imagery and other remotely-sensed data about the Earth, carry out interplanetary and other deep-space exploration missions, and demonstrate new space technologies. This segment also provides space systems and subsystems, including satellite command and data handling, and attitude control and structural subsystems; and a range of space-related technical services, including analytical, engineering, and production services for space-related science and defense programs. The Advanced Space Programs segment develops and produces human-rated systems to be used in earth orbit, planetary exploration, and other space missions; and small and medium-class satellites and related systems used primarily for national security space missions and related technology demonstration programs. It operates in the United States, Europe, Mexico, South America, Australia, and east Asia. The company was founded in 1982 and is headquarter ed in Dulles, Virginia.

Advisors' Opinion:

• [By Chris Katje]

  For those unfamiliar with Orbital Sciences (ORB), the company is a leader in space missions and satellite services. The company operates its business in three segments: launch vehicles, satellites and space systems, and advanced space programs. The company's contract with the International Space System, huge backlog, and human space exploration could send shares much higher than current levels.

• [By Quick Pen]

  The aerospace sector is increasingly becoming competitive. The acquisition proposal comes at a time when another Dulles-based industry player Orbital Sciences (ORB) plans to combine with the defense segment of Alliant Techsystems��(ATK) and emerge as a stronger new entity named Orbital ATK. The defense space has been vastly dominated by the United Launch Alliance, which is a joint venture between Chicago-based aircraft major Boeing (BA) and Lockheed Martin. However, after the $5 billion merger deal to form Orbital ATK is complete, the industry will grow more competitive.

Top Transportation Stocks To Watch Right Now: Ceragon Networks Ltd.(CRNT)

Ceragon Networks Ltd. offers wireless backhaul solutions that enable cellular operators and other wireless service providers to deliver voice and data services. Its wireless backhaul solutions use microwave technology to transfer large amounts of telecommunication traffic between base stations and the core of the service provider?s network. The company offers Internet protocol (IP) based FibeAir IP-10E/IP-MAX2, a high-capacity Ethernet that is used in wireless backhaul for carriers, private networks, and metro area networks; FibeAir IP-10G/IP-MAX2, a high-capacity multi-service, which is used in wireless backhaul for carriers and private networks; FibeAir 2000/4800, an unlicensed multi-service for private networks and business access; FibeAir/1500R, a high-capacity SDH/SONET for wireless backhaul and metro area networks; and FibeAir 3200T, a high-capacity circuit-switched TDM for wireless backhaul and long distance networks. It also provides advanced pure IP/Ethernet solu tions to wireless broadband service providers, as well as to businesses and public institutions that operate their own private communications networks. In addition, the company offers turnkey project services, including network and radio planning, site survey, solutions development, installation, maintenance, and training services. It sells its products through various channels, including direct sales, original equipment manufacturers, resellers, distributors, and system integrators in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. The company was formerly known as Giganet Ltd. and changed its name to Ceragon Networks Ltd. in September 2000. Ceragon Networks Ltd. was founded in 1996 and is headquartered in Tel Aviv, Israel.

Advisors' Opinion:

• [By Vanina Egea]

  Looking forward, Telef贸nica Brasil is investing in technology and network expansion to further empower its competitive position. The firm is expanding its 3G network based on CDMA EV-DO and HSPA technologies, which provide a great advantage over its peers. Further, it expects to benefit from the growth opportunities in the 4G market. Consequently, it has signed a deal with Ceragon Networks Ltd. (CRNT) to deploy the superfast 4G network nationwide.

• [By Peter Graham]

  The third quarter 2014�earnings report for network communication platform maker�Ubiquiti Networks Inc (NASDAQ: UBNT), a peer of small cap stocks�Aviat Networks Inc (NASDAQ: AVNW), Ceragon Networks Ltd (NASDAQ: CRNT) and�DragonWave, Inc (NASDAQ: DRWI), is due out after the market closes on Thursday with shares already trending upwards as they closed 4.08% higher on Tuesday. Aside from the Ubiquiti Networks earnings report, it should be said that Aviat Networks Inc reported earnings yesterday after the market closed (shares were sinking hard in after hours trading); Ceragon Networks Ltd will report earnings before the market opens on Thursday; and DragonWave, Inc is scheduled to report after the market closes next Wednesday. So it�� a busy week for network communications stocks.

Top 10 Mid Cap Stocks To Watch Right Now: Crown Media Holdings Inc.(CRWN)

Crown Media Holdings, Inc., through its subsidiary, Crown Media United States, LLC, owns, operates, and distributes pay television networks for adults and families primarily in the United States. The company operates and distributes Hallmark Channel network to approximately 87 million subscribers through approximately 5,369 cable, satellite, and other pay television distribution systems; and Hallmark Movie Channel network to approximately 45 million subscribers through approximately 2,680 cable, satellite, and other pay television distribution systems. Its networks offers a range of entertainment programming, including television series, movies, miniseries, theatricals, romances, literary classics, and contemporary stories. The company was founded in 1999 and is headquartered in Studio City, California.

Advisors' Opinion:

• [By Equities Lab]

  The stocks that currently pass the stock screen in order of market cap are Frontier Communications Corp , Crown Media Holdings (CRWN), Vonage Holding (VG), MCG Capital Corp (MCGC), 1-800-FLOWERS.COM (FLWS), MTR Gaming Corporation (MNTG), Alaska Communications (ALSK), and Enzon Pharmaceuticals (ENZN).

Top 10 Mid Cap Stocks To Watch Right Now: Ishares Msci Emu Index (EZU)

iShares MSCI EMU Index Fund (the Fund) seeks to provide investment results that correspond generally to the price and yield performance of publicly traded securities in the aggregate in the European Monetary Union (EMU) markets, as measured by the MSCI EMU Index (the Index). The Index seeks to measure the performance of the equity market of the EMU member countries, which includes those members of the European Union who have adopted the Euro as its currency. The Index is a capitalization-weighted index that aims to capture 85% of the (publicly available) total market capitalization. Component companies are adjusted for available float and must meet objective criteria for inclusion in the Index. The Index is reviewed quarterly.

The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Fund�� investment advisor is Barclays Global Fund Advisors.

Advisors' Opinion:

• [By Dave and Donald Moenning]

  At the beginning of the year, those seeing the glass as at least half-empty were expecting Europe (EZU) to drag the economies of the world into recession, China's (FXI) economic growth to tank, the unrest in the Middle East to become a huge problem, the Fed to make a mistake, earnings to soften and the politicians in Washington to send the U.S. into a depression.

Top 10 Mid Cap Stocks To Watch Right Now: Recon Technology Ltd.(RCON)

Recon Technology, Ltd. provides hardware, software, and on-site services to companies in the petroleum mining and extraction industry in the People?s Republic of China. The company offers equipment, tools, and other hardware related to oilfield production and management; and develop and sell industrial automation control and information solutions. Its oil and gas production and transportation equipment comprise heating furnaces, burners, and separators. Recon Technology, Ltd.?s oil and gas development tools and equipment include packers of fracturing, production packers, and water injection packers; and oil and gas production increasing techniques consist of fissure shaper technique to increase perforation depth, sand prevention in oil and water well technique, water locating and plugging technique, fracture acidizing technique, and electronic broken-down service. Its automation systems and services comprise pumping unit controllers that monitors the pumping units and co llects data for load, pressure, voltage, startup, and shutdown control; RTU for monitoring natural gas wells and collecting gas well pressure data; wireless dynamometer and wireless pressure gauge; electric multi-way valve for oilfield metering station flow control; and natural gas flow computer system to measure the flow. The company?s automation systems and services also consist of Recon SCADA oilfield monitor and data acquisition system for supervision and data collection; EPC service of pipeline SCADA system for pipeline monitoring and data acquisition; EPC service of oil and gas wells SCADA system for monitoring and data acquisition of oil, and natural gas wells; EPC service of oilfield video surveillance and control system to control the oil and gas wellhead area and measure station area; and technique service for digital oilfield transformation. Recon Technology, Ltd. was incorporated in 2007 and is headquartered in Beijing, the People?s Republic of China.

Advisors' Opinion:

• [By James E. Brumley]

  Anybody who was lucky enough to get into a Recon Technology, Ltd. (NASDAQ:RCON) position before October 7th, then congratulations - you're up big-time. Now get out. Instead, a better use of that capital is Mitek Systems, Inc. (NASDAQ:MITK). While RCON is overbought and ripe for a pullback, MITK is itching to stage a breakout.

Top 10 Mid Cap Stocks To Watch Right Now: DigitalGlobe Inc (DGI)

DigitalGlobe, Inc. provides commercial earth imagery products and information services worldwide. It collects imagery products and services through its QuickBird, WorldView-1, and WorldView-2 satellites, as well as aerial and satellite imagery from third party suppliers. The company offers a range of online and offline distribution options, including desktop software applications; Web services, which provide direct online access to the company�s image library; file transfer protocol; physical media, such as CD, DVD, and hard drive; and direct access program that facilitates certain customers to task and download data from its WorldView-1 and WorldView-2 satellites. Its imagery products and services support various uses, including defense, intelligence and homeland security, mapping and analysis, environmental monitoring, oil and gas exploration, and infrastructure management. DigitalGlobe, Inc. serves defense contractors; civil government agencies; providers of location-b ased services; and various companies in energy, telecommunications, utility, forestry, mining, financial services, environmental, and agricultural industries through direct and indirect channels. The company was formerly known as EarthWatch, Incorporated and changed its name to DigitalGlobe, Inc. in August 2002. DigitalGlobe, Inc. was founded in 1993 and is headquartered in Longmont, Colorado. DigitalGlobe, Inc. operates as a subsidiary of Morgan Stanley & Co. LLC.

Advisors' Opinion:

• [By Maxx Chatsko]

  The second well-researched pick that worked out in the long run was satellite manufacturer GeoEye. After a few balks, the company was acquired by DigitalGlobe (NYSE: DGI  ) . Similar to Hess, GeoEye was caught in a temporary downturn caused by short-term-minded investors. The company still held the highest-resolution commercial remote-sensing satellite and, despite having a smaller geospatial archive than DigitalGlobe, was 3.6 times more efficient in turning its imagery into revenue. The company was trading at $19 per share 13 months ago, but ended life as an independent company at over $35 per share.

• [By Seth Jayson]

  DigitalGlobe (NYSE: DGI  ) reported earnings on May 7. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended March 31 (Q1), DigitalGlobe missed estimates on revenues and beat expectations on earnings per share.

• [By James Miller Phd]

  The company has a current ratio of 13.05% which is higher than the one registered by Charter Communications Inc. (CHTR), Digital Globe Inc. (DGI), EchoStar Corp (SATS), Gilat Satellite Networks Ltd. (GILT) and Intelsat SA (I).

Top 10 Mid Cap Stocks To Watch Right Now: Sucampo Pharmaceuticals Inc (SCMP)

Sucampo Pharmaceuticals, Inc., incorporated on December 9, 2008, is a global biopharmaceutical company focused on research, discovery, development and commercialization of drugs based on ion channel activators known as prostones. The Company�� prostone-based compounds target the ClC-2 and big potassium (BK), ion channels. It is focused on developing prostones to treat gastrointestinal, ophthalmic, neurologic, and oncology-based inflammatory disorders, and is also considering other therapeutic applications of its drug technology. The Company�� products include AMITIZA (lubiprostone) and RESCULA (unoprostone isopropyl).

AMITIZA

The Company�� AMITIZA is being marketed in the United States for three gastrointestinal indications under a license agreement, or the Takeda Agreement, with Takeda Pharmaceutical Company Limited, or Takeda. The three gastrointestinal indications include chronic idiopathic constipation (CIC), in adults, irritable bowel syndrome with constipation (IBS-C), in adult women, and opioid-induced constipation (OIC), in adult patients with chronic, non-cancer pain. AMITIZA for OIC received approval from the United States Food and Drug Administration (FDA), in April 2013. In Japan, AMITIZA is marketed under a license, commercialization and supply agreement, or the Abbott Agreement, with Abbott Japan Co. Ltd. (Abbott), for the gastrointestinal indication of chronic constipation (CC), excluding constipation caused by organic diseases. In Switzerland, the Company is marketing AMITIZA.

RESCULA

The Company holds license agreements for RESCULA in the United States and Canada and the rest of the world, with the exception of Japan, Korea, Taiwan and the People�� Republic of China. The Company is commercializing RESCULA (unoprostone isopropyl ophthalmic solution) 0.15% for the lowering of intraocular pressure (IOP), in patients with open-angle glaucoma or ocular hypertension in the United States. RESCULA may be used as an agent or concomit! antly with other topical ophthalmic drug products to lower intraocular pressure. RESCULA is a BK channel activator and has a different mechanism of action than other IOP lowering agents on the market.

Advisors' Opinion:

• [By Roberto Pedone]

  Another under-$10 stock that's starting to trend within range of triggering a major breakout trade is Sucampo Pharmaceuticals (SCMP), which is engaged in the discovery, development and commercialization of proprietary drugs based on prostones, and other novel drug technologies. This stock is off to a decent start in 2013, with shares up by 26%.

  If you take a look at the chart for Sucampo Pharmaceuticals, you'll notice that this stock has been downtrending badly for the last four months, with shares dumping hard from its high of $10.48 to its recent low of $5.40 a share. During that downtrend, shares of SCMP have been consistently making lower highs and lower lows, which is bearish technical price action. That said, the downside volatility for SCMP looks to be over in the short-term since the stock has started to reverse its downtrend and enter an uptrend. That reverse is quickly pushing shares of SCMP within range of triggering a major breakout trade above a key downtrend line.

  Traders should now look for long-biased trades in SCMP if it manages to break out above some near-term overhead resistance levels at $6.33 to $6.66 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 115,383 shares. If that breakout triggers soon, then SCMP will set up to re-test or possibly take out its next major overhead resistance levels at $7.09 to $7.67 a share. Any high-volume move above those levels will then give SCMP a chance to tag $8 to $9 a share.

  Traders can look to buy SCMP off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $5.58 to $5.40 a share. One can also buy SCMP off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

• [By James Brumley]

  Still, for the nimble who know when to get out, OREX is one of the few cheap stocks worth a closer look.

  Sucampo Pharmaceuticals (SCMP)

  Finally, though the price of $7.60 clearly qualifies it as one pf the cheapest of the cheap stocks out there in the pharmaceutical world, that’s not the reason Sucampo Pharmaceuticals (SCMP) may be worth a look here. It’s the 30% slide we’ve seen SCMP stock suffer since peaking in mid-January. It’s not a pullback that’s bound to go unchallenged by the bulls.

Top 10 Mid Cap Stocks To Watch Right Now: Manulife Financial Corp (MFC)

Manulife Financial Corporation (MFC) is a Canada-based financial services group with principal operations in Asia, Canada and the United States. The Company�� segments are Asia, Canadian and U.S. Divisions and the Corporate and Other segment. The Company�� international network agents and distribution partners offers financial protection and wealth management products and services to clients. It also provides asset management services to institutional customers. In January 2013, the Company acquired Benesure Canada Inc. In August 2013, John Hancock, the United States division of the Company, announced that it has acquired Landmark Square in Long Beach, California. In December 2013, MFC announced its subsidiary, Manulife (International) Limited, had completed the transaction to sell its life insurance business in Taiwan to CTBC Life Insurance Co., Ltd. Advisors' Opinion:

• [By Eric Lam]

  Air Canada, the nation�� largest airline, surged 7.2 percent after reducing costs. Manulife Financial Corp. (MFC), Canada�� largest insurer, increased 2.6 percent for a fourth day of gains. Trilogy Energy Corp. plunged 9.8 percent after reporting a loss as sales declined. Detour Gold Corp. plunged 18 percent after saying it will not meet its 2013 production targets. Centerra Gold Inc. and HudBay Minerals Inc. sank at least 3.7 percent as gold dropped to a three-week low in New York.

• [By Jonas Elmerraji]

  Manulife Financial (MFC) is another stock that's forming an ascending triangle pattern right now. In the case of this $33 billion Canadian financial services firm, resistance comes into play at $18, a price level that's acted as a ceiling for shares since all the way back in July. The buy signal comes on a move through that $18 barrier.

  Whenever you're looking at any technical price pattern, it's critical to think in terms of those buyers and sellers. Triangles, and other pattern names are a good quick way to explain what's going on in a stock, but they're not the reason it's tradable. Instead, it all comes down to supply and demand for shares.

  That $18 resistance level is a price where there has been an excess of supply of shares; in other words, it's a place where sellers have been more eager to step in and take gains than buyers have been to buy. That's what makes a breakout above it so significant -- the move means that buyers are finally strong enough to absorb all of the excess supply above that price level.

  After it happens, I'd recommend keeping a protective stop at $16.50.

• [By Patricio Kehoe] est Canadian life insurer by market capitalization, offering asset management, wealth management and financial services to customers in Asia, Canada and the U.S. However, the company�� annuity and segregated fund business has suffered over the past two years, due to the low interest rate environment, leading to a decline in earnings and operating results. Nonetheless, the firm has been undergoing some changes throughout 2013 and management expects profitability to increase for fiscal 2014, despite its underperformance during fourth quarter fiscal 2013. Thus, many investment gurus like George Soros (Trades, Portfolio) and Jim Simons' (Trades, Portfolio) hedge fund remain bullish about Manulife�� future outlook, evidenced by their shares purchased in the past quarter.

  Of Hedging and Repricing

  Manulife�� capital sensitivity and volatile earnings have made it difficult for the company to maintain steady growth prospects in the past, but quarter four's earnings report showed improvements in some aspects, especially regarding EPS growth, which jumped 73% year over year, closing at $1.62 per share. This is largely due to the company�� recent strategy of hedging two-thirds of its variable annuity business, and looking forward all newly written businesses in this segment will be hedged. Furthermore, the firm has been gradually trading most of its short-term bonds for long-term bonds, which will improve the bond duration of its investment portfolio, thereby reducing earning sensitivity. While insurance sales were weak for 2013, declining 13% from 2012 and 32% year over year for the quarter, Manulife�� shift towards expanding its wealth management business (wealth sales increased 37% over the past fiscal year) and mutual fund sales should help offset declines in the future.

  In fact, today the company announced that it will be launching a new universal life product for the Canadian market called Manulife UL by May 26 of this year. The new

Top 10 Mid Cap Stocks To Watch Right Now: SOHM Inc (SHMN)

SOHM, Inc. is a global generic pharmaceutical manufacturer, developer and marketer having a range of products, covering the therapeutic segments. The Company has its presence in healthcare segments, such as nutraceuticals, dermatology and all other therapeutic segments.

The Company�� generic pharmaceuticals are exported globally with a focus on distribution in Africa, Latin America and Southeast Asia. The Company�� products has presence in analgesic, anti-flammatory, drops, suspensions, vitamins and tonics, antibiotics, beta-lactum antibiotics, injections, syrups, anti-cold, capsules, nutraceutical and tablets.

Advisors' Opinion:

• [By Peter Graham]

  Small cap stocks VizStar Inc (OTCMKTS: VIZS), SOHM Inc (OTCMKTS: SHMN) and American Soil Technologies, Inc (OTCMKTS: SOYL) have been getting some attention in various investment newsletters with two out of three of these stocks being the subject of paid promotions. However, there is nothing wrong with some paid for attention so long as everything is properly disclosed, but its going to be up to investors and traders alike to ultimately decide whether any of these stocks have what it takes to be the next hot stock. With that in mind, here is a quick reality check about all three small cap stocks: